-+ 0.00%
-+ 0.00%
-+ 0.00%

NUCANA PLC - SIGNIFICANT TUMOR REDUCTIONS IN PD-(L)1 EXPERIENCED PATIENTS WITH NUC-3373 PLUS PEMBROLIZUMAB

Reuters·11/11/2024 12:00:01

Please log in to view news